BMI's Business Environment Ratings for the Middle East and Africa (MEA) pharmaceutical market underline some of our key views about how the sector is performing in emerging markets. In particular, we highlight Saudi Arabia, Egypt and Ghana as the most positive and promising, while the UAE and South Africa will continue as the main investment focuses. We draw attention to Ghana, newly added to our ratings, which has entered at a respectable regional ranking of 15th out of 19. In MEA terms this is quite low, but in terms of our Sub-Saharan African market coverage only South Africa has a higher score with 53.5, compared to Ghana's 39.1. Since South Africa benefits from a longer history of established health and social infrastructure and is a base for most multinational drugmakers looking for an entry point into Africa, its higher score is to be expected. Morocco's pharmaceutical business environment is ranked in between Iran and Oman in BMI's Q310 Business Environment Ratings. An overall score of 46.4 out of 100 puts it in ninth place out of 19 Middle East and Africa markets in our regional universe. In 2008, the Moroccan Ministry of Health said it had hired an extra 340 specialist doctors and 203 general practitioners, reported Maghreb Arab Press (MAP). Meanwhile, 1,234 nurses have been recruited, as well as 27 dentists and 15 pharmacists ' an increase of over 150% on 2007 levels. In 2009, the number of medical, paramedical and administrative health workers rose by 20.6% from 2007 and 2008. The government recruited 1,100 paramedics in 2008 and 1,500 in 2009 and has launched an initiative to train 3,300 doctors by 2020. According to Minister of Health Yasmina Baddou, the current finance bill (2010) contains provisions for the recruitment for 2,000 posts in the healthcare sector. BMI welcomes the government's focus on increasing medical personnel numbers ' the lack of which has created an uneven distribution of medical workers and facilities across the country, leaving people in some areas without access to quality medical care. Further highlighting increasing government focus on healthcare provision, in March 2010 the health authorities in Morocco started a campaign to fight cancer in the country by opening new treatment centres and expanding healthcare coverage. The disease accounts for 7.2% of deaths annually, with 3,000 new cases diagnosed each year. The MAD8bn campaign aims to make treatment, detection and preventive care more accessible. The anti-cancer campaign will also expand cancer patients' right to receive healthcare benefits, helping to offset the high treatment costs ' which is crucial as more than 50% of patients do not have any health insurance and, according to the Ministry of Health, up to 90% of the treatment costs for some types of cancer are borne by the patients.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Morocco Pharmaceuticals and Healthcare Report Q3 2010
Published on July 2010
Report Summary
BMI's Business Environment Ratings for the Middle East and Africa (MEA) pharmaceutical market underline some of our key views
about how the sector is performing in emerging markets. In particular, we highlight Saudi Arabia, Egypt and Ghana as the most
positive and promising, while the UAE and South Africa will continue as the main investment focuses. We draw attention to Ghana,
newly added to our ratings, which has entered at a respectable regional ranking of 15th out of 19. In MEA terms this is quite low, but
in terms of our Sub-Saharan African market coverage only South Africa has a higher score with 53.5, compared to Ghana's 39.1.
Since South Africa benefits from a longer history of established health and social infrastructure and is a base for most multinational
drugmakers looking for an entry point into Africa, its higher score is to be expected. Morocco's pharmaceutical business environment
is ranked in between Iran and Oman in BMI's Q310 Business Environment Ratings. An overall score of 46.4 out of 100 puts it in ninth
place out of 19 Middle East and Africa markets in our regional universe.
In 2008, the Moroccan Ministry of Health said it had hired an extra 340 specialist doctors and 203 general practitioners, reported
Maghreb Arab Press (MAP). Meanwhile, 1,234 nurses have been recruited, as well as 27 dentists and 15 pharmacists ' an increase of
over 150% on 2007 levels. In 2009, the number of medical, paramedical and administrative health workers rose by 20.6% from 2007
and 2008. The government recruited 1,100 paramedics in 2008 and 1,500 in 2009 and has launched an initiative to train 3,300
doctors by 2020. According to Minister of Health Yasmina Baddou, the current finance bill (2010) contains provisions for the
recruitment for 2,000 posts in the healthcare sector.
BMI welcomes the government's focus on increasing medical personnel numbers ' the lack of which has created an uneven
distribution of medical workers and facilities across the country, leaving people in some areas without access to quality medical care.
Further highlighting increasing government focus on healthcare provision, in March 2010 the health authorities in Morocco started a
campaign to fight cancer in the country by opening new treatment centres and expanding healthcare coverage. The disease accounts
for 7.2% of deaths annually, with 3,000 new cases diagnosed each year. The MAD8bn campaign aims to make treatment, detection
and preventive care more accessible. The anti-cancer campaign will also expand cancer patients' right to receive healthcare benefits,
helping to offset the high treatment costs ' which is crucial as more than 50% of patients do not have any health insurance and,
according to the Ministry of Health, up to 90% of the treatment costs for some types of cancer are borne by the patients.
Table of Content
Executive Summary ... 5
SWOT Analysis ... 6
Morocco Pharmaceuticals And Healthcare Industry SWOT ... 6
Pharmaceutical Business Environment Ratings ...... 7
Table: Middle East and Africa Pharmaceutical Business Environment Ratings, Q310 ...... 7
Limits To Potential Returns .... 8
Risks To Realisation Of Returns .... 9
Market Summary ' Morocco .. 10
Regulatory Regime .. 13
Industry Developments .. 15
Epidemiology .. 15
Table: Leading Causes Of Death In Morocco, 2002 ...... 17
Morocco Pharmaceuticals and Healthcare Report Q3 2010 Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Healthcare Sector... 17
Healthcare Reforms ...... 19
Health Insurance .... 21
Pharmaceutical Sector .. 22
Pharmaceutical Distribution 25
Research & Development ..... 25
Industry Forecast Scenario ... 26
Overall Market Forecasts .... 26
Key Growth Factors ' Industry ... 27
Key Growth Factors ' Macroeconomic Forecast .... 29
Table: Morocco Economic Activity, 2007-2014 ...... 30
Prescription Drug Market Forecast ... 31
Patented Product Market Forecast .... 32
Generic Drug Market Forecast ... 33
OTC Medicine Market Forecast .. 34
Medical Device Market Forecast 35
Pharmaceutical Trade Forecast .. 37
Other Healthcare Data Forecasts ...... 38
Key Risks To BMI's Forecasts .... 38
Competitive Landscape . 39
Company Profiles .... 40
Sothema .... 40
Laprophan 41
Promopharm ... 42
Multinational Company Profiles . 43
Sanofi-Aventis . 43
Pfizer . 44
GlaxoSmithKline .... 44
Country Snapshot: Morocco Demographic Data ... 45
Section 1: Population .... 45
Table: Demographic Indicators, 2005-2030 .... 45
Table: Rural/Urban Breakdown, 2005-2030 .... 46
Section 2: Education And Healthcare 46
Table: Education, 2002-2005 ...... 46
Table: Vital Statistics, 2005-2030 ...... 46
Section 3: Labour Market And Spending Power ..... 47
Table: Employment Indicators, 2001-2006 ...... 47
Table: Consumer Expenditure, 2000-2012 (US$) ... 47
BMI Methodology ..... 48
Ratings Overview ... 49
Table: Pharmaceutical Business Environment Indicators ..... 50
Weighting . 51
Table: Weighting Of Components ...... 51
Forecast Tables. 52
Morocco Pharmaceuticals and Healthcare Report Q3 2010 Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Morocco Pharmaceuticals and Healthcare Report Q3 2010
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 530.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Morocco Pharmaceuticals and Healthcare Report Q3 2010 Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Morocco Pharmaceuticals and Healthcare Report Q3 2010 Page 4/4